RT Book, Section A1 Whalen, Karen A1 Sando, Karen R. A2 Whalen, Karen A2 Hardin, Heather C. SR Print(0) ID 1150199834 T1 Diabetes Mellitus MTM Data Set T2 Medication Therapy Management: A Comprehensive Approach, 2e YR 2018 FD 2018 PB McGraw-Hill Education PP New York, NY SN 9781260108453 LK accesspharmacy.mhmedical.com/content.aspx?aid=1150199834 RD 2024/03/29 AB KEY POINTSIntensive glycemic control can reduce microvascular complications of diabetes. The hemoglobin A1c goal for most patients is <7%; however, goals for glycemic control should be individualized based on presence of concurrent illness or complications, risk of hypoglycemia, and life expectancy. To reduce macrovascular complications, management of cardiac risk factors such as hypertension and hyperlipidemia is necessary; reductions in glycemic control alone are unlikely to prevent significant cardiovascular morbidity and mortality.Medication therapy management (MTM) providers should work with the patient and members of the healthcare team to tailor medication regimens that achieve therapeutic goals, promote adherence, reduce the risk of complications, and maximize quality of life for patients with diabetes.